Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc.（PIRS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pirs · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年2月11日
分析师评级与共识
基于过去 3 个月内 2 位华尔街分析师
Buy
2 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $13.60
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $13.52 | ↓ 0.61% |
1-day model range: $13.29–$13.74. Peak: $13.74 (-0.61%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PIRS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2020-03-13 | Baird | Upgrade ↑ | Neutral→Outperform |
| 2020-03-12 | Baird | Upgrade ↑ | Neutral→Outperform |
| 2019-07-30 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2019-07-29 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2016-03-09 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2016-03-08 | JMP Securities | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on Pieris Pharmaceuticals, Inc. (PIRS) stock. Of the recent 6 rating actions, 2 were upgrades and 2 were downgrades. 2 analysts currently cover PIRS.
分析师推荐趋势
PIRS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$27M
↑ 301.0% YoY
Revenue Next Year
$32M
↑ 20.4% YoY
EPS This Year
$-50.74
EPS Next Year
$-28.00
↓ 44.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast PIRS EPS of $-50.74 for the current fiscal year, based on estimates from 1 analysts. The PIRS revenue forecast is $27M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PIRS 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PIRS 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
PIRS 的短期预测（明日）为 $13.52（-0.61%）。
Pieris Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 PIRS。PIRS 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
PIRS 预测 · 8 个问题根据 2 位华尔街分析师，PIRS 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $13.60，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.